To determine the link between the IgA-aβ<sub>2</sub>GPI antibodies and APS-events in asymptomatic individuals before recommending preventive treatments, there needs to be a broader intention to standardize IgA-aβ<sub>2</sub>GPI assays as a diagnostic criterion for APS. Here, CD79A is linked to autoimmune polyendocrinopathy.